Specialists for Aggressive NK-cell leukemia

32 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

David Maloney
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×11
Mitchell Cairo, MD, MD
Rare Disease / Clinical Research
New York Medical College
HAWTHORNE, NY
PI×11
Alison Moskowitz, MD, LCSW
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
FAIRFIELD, CT
PI×6 1
Wyndham H Wilson, M.D., MD, PhD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×8
Steven Horwitz, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×4
Ryotaro Nakamura
Rare Disease Specialist
City of Hope Medical Center
Duarte, California
PI×6
Thomas E. Witzig, MD, M.D
Rare Disease / Clinical Research
Mayo Clinic
ROCHESTER, MN
PI×9
George Chen
Rare Disease / Clinical Research
Roswell Park Cancer Institute
PI×2
Nancy Wells, DNSc, RN
Rare Disease / Clinical Research
Vanderbilt-Ingram Cancer Center
PI×2
Elizabeth Fox, MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×5
Yasuhiro Oki, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×1
Won Seog Kim, MD, PhD
Rare Disease / Clinical Research
Samsung Medical Center
PI×7
Hongtao Liu
Rare Disease / Clinical Research
University of Chicago Comprehensive Cancer Center
MADISON, WI
PI×4
Wan-Jen Hong, MD, M.D
Rare Disease / Clinical Research
Dren Bio
STANFORD, CA
PI×1
John Sarantopoulos, M.D
Rare Disease / Clinical Research
SWOG Cancer Research Network
SAN ANTONIO, TX
PI×2 2
Pierluigi Porcu, M.D
Rare Disease / Clinical Research
Ohio State University
PHILADELPHIA, PA
PI×2
Brian Hill, MD
Rare Disease / Clinical Research
Case Comprehensive Cancer Center
PI×1
Thomas A Waldmann, M.D.
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×6
Ann Woolfrey, M.D
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×5
Helen Heslop, MD, MD
Rare Disease / Clinical Research
Baylor College of Medicine
HOUSTON, TX
PI×6
Tom R. Fitch, M.D.
Rare Disease / Clinical Research
Mayo Clinic
GLENDALE, AZ
PI×1
Mohamed Sorror, M.D., M.Sc
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
PI×4 1
Minoti Hiremath, MD
Rare Disease / Clinical Research
Atara Biotherapeutics
PI×2
Paul Armistead, MD, M.D., PhD
Rare Disease / Clinical Research
UNC Lineberger Comprehensive Cancer Center
CHAPEL HILL, NC
PI×1
Yi Liao
Rare Disease / Clinical Research
The First Affiliated Hospital of Wannan Medical College
2
Thomas Waldmann
National Cancer Institute, National Institutes of Health
QC-verified PI×2
Jonathan Brammer, D.D.S
Ohio State University
WICHITA, KS
QC-verified PI×1
Tonya M. Peele
GlaxoSmithKline
QC-verified PI×1
Lubomir Sokol, MD
H. Lee Moffitt Cancer Center and Research Institute
TAMPA, FL
QC-verified PI×3
Sa A Wang
Rare Disease / Clinical Research
The University of Texas MD Anderson Cancer Center
TX
2
Tapan Kadia, M.D
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×5
Thomas P. Loughran, M.D
Milton S. Hershey Medical Center
CHARLOTTESVILLE, VA
QC-verified PI×2

More about Aggressive NK-cell leukemia